$SWAG
Stran & Company, Inc. Stock $swag

$swag Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072154 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$27.95M	$13.58M	$10.95M
YoY Change	121.33%	24.01%	30.89%
Cost Of Revenue	$14.60M	$9.329M	$7.223M
YoY Change	63.09%	29.15%	16.53%
Gross Profit	$13.35M	$4.247M	$3.725M
YoY Change	263.21%	14.03%	72.03%
Gross Profit Margin	47.76%	31.29%	34.02%
Selling, General & Admin	$24.52M	$4.896M	$2.689M
YoY Change	522.15%	82.08%	29.32%
% of Gross Profit	183.68%	115.28%	72.2%
Research & Development	$1.103M	$1.400M
YoY Change
% of Gross Profit	8.26%	32.96%
Depreciation & Amortization	$194.0K	$187.4K	$145.8K
YoY Change	71.36%	28.48%	7.74%
% of Gross Profit	1.45%	4.41%	3.91%
Operating Expenses	$25.81M	$4.896M	$2.689M
YoY Change	555.07%	82.08%	29.32%
Operating Profit	-$12.47M	-$649.0K	$1.036M
YoY Change	4589.49%	-162.67%	1108.95%
Interest Expense	$10.51M	$12.80K	-$26.26K
YoY Change	-14990.93%	-148.74%
% of Operating Profit			-2.54%
Other Income/Expense, Net	-$1.874M	-$213.6K	$6.380K
YoY Change	121.98%	-3448.34%
Pretax Income	-$3.828M	-$862.7K	$1.016M
YoY Change	832.27%	-184.93%	1085.75%
Income Tax	-$914.0K	-$174.5K	$291.8K
% Of Pretax Income			28.73%
Net Earnings	-$2.914M	-$688.2K	$723.9K
YoY Change	9727.99%	-195.07%	-413.34%
Net Earnings / Revenue	-10.43%	-5.07%	6.61%
Basic Earnings Per Share		-$0.03	$0.07
Diluted Earnings Per Share	-$0.27	-$0.02	$50.49K
COMMON SHARES
Basic Shares Outstanding	18.63M shares	19.14M shares	10.00M shares
Diluted Shares Outstanding		31.38M shares	10.00M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.39M	$21.98M	$797.4K
YoY Change	-52.26%	2656.46%
Cash & Equivalents	$15.25M	$12.30M	$797.4K
Short-Term Investments	$9.780M	$9.684M
Other Short-Term Assets	$2.539M	$1.289M	$4.479M
YoY Change	126.04%	-71.23%
Inventory	$6.868M	$7.118M	$108.5K
Prepaid Expenses
Receivables	$14.44M	$10.30M	$7.266M
Other Receivables	$0.00	$0.00	$459.6K
Total Short-Term Assets	$48.57M	$40.69M	$13.11M
YoY Change	2.11%	210.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.000M	$804.6K	$1.769M
YoY Change	62.4%	-54.53%
Goodwill
YoY Change
Intangibles	$6.272M	$5.459M
YoY Change	225.1%
Long-Term Investments	$7.404M	$11.68M	$231.5M
YoY Change	-96.8%	-94.96%
Other Assets	$1.074M	$2.166M	$0.00
YoY Change
Total Long-Term Assets	$8.057M	$7.128M	$3.753M
YoY Change	121.35%	89.91%
TOTAL ASSETS
Total Short-Term Assets	$48.57M	$40.69M	$13.11M
Total Long-Term Assets	$8.057M	$7.128M	$3.753M
Total Assets	$56.63M	$47.81M	$16.86M
YoY Change	10.59%	183.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.61M	$2.847M	$5.804M
YoY Change	293.4%	-50.95%
Accrued Expenses	$12.14M	$1.018M	$1.220M
YoY Change	957.97%	-16.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$162.4K	$3.662M
YoY Change	-100.0%	-95.57%
Long-Term Debt Due	$1.810M	$1.781M	$878.7K
YoY Change		102.63%
Total Short-Term Liabilities	$13.96M	$6.598M	$12.99M
YoY Change	78.21%	-49.19%
LONG-TERM LIABILITIES
Long-Term Debt	$60.85M	$2.201M	$1.122M
YoY Change	6134.33%	96.13%
Other Long-Term Liabilities	$32.99M	$539.7K	$864.1K
YoY Change	4104.13%	-37.53%
Total Long-Term Liabilities	$3.306M	$2.741M	$1.986M
YoY Change	87.76%	37.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.96M	$6.598M	$12.99M
Total Long-Term Liabilities	$3.306M	$2.741M	$1.986M
Total Liabilities	$17.26M	$9.339M	$14.97M
YoY Change	79.96%	-37.62%
SHAREHOLDERS EQUITY
Retained Earnings	$1.084M	$180.6K
YoY Change	-41.81%
Common Stock	$1.848K	$1.854K
YoY Change	-6.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$6.668M
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.36M	$38.47M	$1.893M
YoY Change
Total Liabilities & Shareholders Equity	$56.63M	$47.81M	$16.86M
YoY Change	10.59%	183.51%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.914M	-$688.2K	$723.9K
YoY Change	9727.99%	-195.07%	-413.34%
Depreciation, Depletion And Amortization	$194.0K	$187.4K	$145.8K
YoY Change	71.36%	28.48%	7.74%
Cash From Operating Activities	-$1.301M	-$3.907M	-$675.3K
YoY Change	-66.99%	478.55%	113.88%
INVESTING ACTIVITIES
Capital Expenditures	-$155.0K	-$160.6K	-$96.13K
YoY Change	108.05%	67.03%	-3.61%
Acquisitions
YoY Change
Other Investing Activities	-$796.0K	-$9.930M	-$231.5M
YoY Change		-95.71%
Cash From Investing Activities	-$641.0K	-$10.09M	-$96.13K
YoY Change	760.4%	10396.4%	-3.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-1.908M	1.334M
YoY Change	-100.0%	-242.99%	-205.21%
NET CHANGE
Cash From Operating Activities	-1.301M	-3.907M	-675.3K
Cash From Investing Activities	-641.0K	-10.09M	-96.13K
Cash From Financing Activities	0.000	-1.908M	1.334M
Net Change In Cash	-1.942M	-15.91M	562.9K
YoY Change	-106.18%	-2925.69%	-133.43%
FREE CASH FLOW
Cash From Operating Activities	-$1.301M	-$3.907M	-$675.3K
Capital Expenditures	-$155.0K	-$160.6K	-$96.13K
Free Cash Flow	-$1.146M	-$3.746M	-$579.2K
YoY Change	-70.37%	546.85%	168.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41038
	dei	Entity Registrant Name EntityRegistrantName	STRAN & COMPANY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3297200
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Heritage Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02171
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	STRN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18632115	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12296662	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32226668	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	9684208	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10297020	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8982768	usd
CY2022Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	545800	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	113000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	7118378	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	5230792	usd
CY2022Q3	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	342323	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	623402	usd
CY2022Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	313183	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	299411	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	40685033	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47563500	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	804607	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	615837	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5459240	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1929294	usd
CY2022Q3	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	864050	usd
CY2021Q4	strn	Right Of Use Asset Office Leases RightOfUseAssetOfficeLeases	1094778	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	6323290	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	3024072	usd
CY2022Q3	us-gaap	Assets Assets	47812930	usd
CY2021Q4	us-gaap	Assets Assets	51203409	usd
CY2022Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1780578	usd
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	665855	usd
CY2022Q3	strn	Current Obligation Under Right Of Use Asset Office Leases CurrentObligationUnderRightOfUseAssetOfficeLeases	324309	usd
CY2021Q4	strn	Current Obligation Under Right Of Use Asset Office Leases CurrentObligationUnderRightOfUseAssetOfficeLeases	310095	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2846934	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4983496	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	693626	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	836915	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	569358	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	721608	usd
CY2021Q4	strn	Reward Program Liability RewardProgramLiability	43878	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	221157	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	106824	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	162358	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	162358	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6598320	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7831029	usd
CY2022Q3	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	-2200844	usd
CY2021Q4	strn	Long Term Wildman Contingent Earn Out Liability LongTermWildmanContingentEarnOutLiability	-976078	usd
CY2022Q3	strn	Long Term Obligation Under Right Of Use Asset Office Leases LongTermObligationUnderRightOfUseAssetOfficeLeases	-539741	usd
CY2021Q4	strn	Long Term Obligation Under Right Of Use Asset Office Leases LongTermObligationUnderRightOfUseAssetOfficeLeases	-784683	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2740585	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1760761	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38291586	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39747649	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18537410	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18537410	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19753852	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19753852	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1854	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1976	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	180585	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1861994	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	38474025	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47812930	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51203409	usd
CY2022Q3	us-gaap	Revenues Revenues	13576072	usd
CY2021Q3	us-gaap	Revenues Revenues	10947724	usd
	us-gaap	Revenues Revenues	40642559	usd
	us-gaap	Revenues Revenues	27075116	usd
CY2022Q3	strn	Purchases Expenses PurchasesExpenses	8388856	usd
CY2021Q3	strn	Purchases Expenses PurchasesExpenses	6362217	usd
	strn	Purchases Expenses PurchasesExpenses	25843023	usd
	strn	Purchases Expenses PurchasesExpenses	16435550	usd
CY2022Q3	strn	Freight Expenses FreightExpenses	939865	usd
CY2021Q3	strn	Freight Expenses FreightExpenses	860813	usd
	strn	Freight Expenses FreightExpenses	3573830	usd
	strn	Freight Expenses FreightExpenses	2478457	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9328721	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7223030	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29416853	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18914007	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4247351	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3724694	usd
	us-gaap	Gross Profit GrossProfit	11225706	usd
	us-gaap	Gross Profit GrossProfit	8161109	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4896386	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2689101	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13152774	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8333132	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4896386	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2689101	usd
	us-gaap	Operating Expenses OperatingExpenses	13152774	usd
	us-gaap	Operating Expenses OperatingExpenses	8333132	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-649035	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1035593	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1927068	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-172023	usd
	us-gaap	Other Expenses OtherExpenses	27461	usd
CY2022Q3	us-gaap	Other Income OtherIncome	20471	usd
CY2021Q3	us-gaap	Other Income OtherIncome	6378	usd
	us-gaap	Other Income OtherIncome	119585	usd
	us-gaap	Other Income OtherIncome	776440	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	12800	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	26260	usd
	us-gaap	Interest Expense InterestExpense	18942	usd
	us-gaap	Interest Expense InterestExpense	66066	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	9919	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9919	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-231214	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-231214	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-213624	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19882	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-148113	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	710374	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-862659	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1015711	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2075181	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	538351	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-174507	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	291843	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-393772	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	273457	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-688152	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	723868	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1681409	usd
	us-gaap	Net Income Loss NetIncomeLoss	264894	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19702136	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19702136	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31381151	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31381151	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10000000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1627755	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290085	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1337670	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-168889	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1168781	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	723868	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1892649	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	1307362	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	118692	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	42591859	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	48291	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1993510	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-447443	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	40199197	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	45385	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1182405	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-688152	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	38474025	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1681409	usd
	us-gaap	Net Income Loss NetIncomeLoss	264894	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-432800	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	159838	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	496827	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	333495	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	770061	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	80704	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	63204	usd
	strn	Reduction In Wildman Earn Out Payment ReductionInWildmanEarnOutPayment	140746	usd
	strn	Reduction In Wildman Earn Out Payment ReductionInWildmanEarnOutPayment	69584	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	212368	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	14295	usd
	strn	Unrealized Loss On Short Term Investments UnrealizedLossOnShortTermInvestments	231214	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1314252	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1586786	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	459638	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	108476	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1887586	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1412425	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13772	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	89735	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	281079	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-30479	usd
	strn	Increase Decrease In Account Payable And Accrued Liabilities IncreaseDecreaseInAccountPayableAndAccruedLiabilities	-2136562	usd
	strn	Increase Decrease In Account Payable And Accrued Liabilities IncreaseDecreaseInAccountPayableAndAccruedLiabilities	2536006	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-143289	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-107461	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-231980	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-152250	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	56615	usd
	strn	Rewards Program Liability RewardsProgramLiability	43878	usd
	strn	Rewards Program Liability RewardsProgramLiability	129392	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	114333	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	23004	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6515724	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1558961	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	540290	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	350108	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	314448	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	9929617	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10820015	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314448	usd
	strn	Note Payable Line Of Credits NotePayableLineOfCredits	4225000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2375000	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	525109	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	333146	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-506748	usd
	strn	Net Working Deficit Received In Asset Acquisition NetWorkingDeficitReceivedInAssetAcquisition	194115	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3182405	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1307362	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2594267	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2023602	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19930006	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	150193	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32226668	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	647235	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12296662	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	797428	usd
	us-gaap	Interest Paid Net InterestPaidNet	4747	usd
	us-gaap	Interest Paid Net InterestPaidNet	66066	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	85163	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	360906	usd
	strn	Cost Of Intangible Asset Customer List CostOfIntangibleAssetCustomerList	364552	usd
	strn	Equipment Acquired In Asset Acquisition EquipmentAcquiredInAssetAcquisition	-14444	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	350108	usd
	strn	Non Cash Wildman Business Group Llc Asset Acquisition NonCashWildmanBusinessGroupLLCAssetAcquisition	2416048	usd
	strn	Non Cash Gap Promotions Llc Asset Acquisition NonCashGAPPromotionsLLCAssetAcquisition	1735000	usd
	strn	Non Cash Trend Inc Asset Acquisition NonCashTrendIncAssetAcquisition	1470344	usd
	us-gaap	Stock Issued1 StockIssued1	3205344	usd
	us-gaap	Stock Issued1 StockIssued1	2416048	usd
CY2022Q3	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	231214	usd
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9684208	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	231214	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	231214	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	9915422	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	292847	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	302929	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6708578	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4124738	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	409800	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1106054	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	7118378	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	5230792	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5664	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	485424	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	410030	usd
CY2022Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1265110	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	975952	usd
CY2022Q3	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
CY2021Q4	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	62424	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1818622	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1454070	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1014015	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	838233	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	804607	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	615837	usd
CY2022Q3	strn	Cost Of Sale Purchases CostOfSalePurchases	2351553	usd
CY2021Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	2109427	usd
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	495381	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2874069	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2846934	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4983496	usd
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2021Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
CY2022Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.05	pure
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0675	pure
CY2021	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.04	pure
CY2022Q3	strn	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	191054	usd
CY2022Q3	strn	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	864050	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.02	pure
	strn	Warrants Outstanding WarrantsOutstanding	4328495	shares
	strn	Warrants Outstanding WarrantsOutstanding	0	shares
CY2021Q4	strn	Outstanding Voting Stock Percentage OutstandingVotingStockPercentage	0.654	pure
CY2021Q4	strn	Private Placement Exercise Price PrivatePlacementExercisePrice	1
	strn	Warrant Exercised WarrantExercised	0	shares
	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	569358	usd
CY2021	us-gaap	Deferred Revenue Refund Payments1 DeferredRevenueRefundPayments1	721608	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	721608	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	564227	usd
	strn	Revenue Recognized RevenueRecognized	-40642559	usd
CY2021	strn	Revenue Recognized RevenueRecognized	-39702714	usd
	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	40490309	usd
CY2021	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	39860095	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	569358	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	721608	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	0	usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	43878	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	162358	usd
CY2022Q3	strn	Amount Accrues No Interest AmountAccruesNoInterest	162358	usd
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	2193166	usd
CY2022Q3	strn	Right Of Use Assets RightOfUseAssets	864050	usd
CY2021Q4	strn	Right Of Use Assets RightOfUseAssets	1094778	usd
CY2022Q3	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	324309	usd
CY2021Q4	strn	Right Of Use Asset Office Leases Current RightOfUseAssetOfficeLeasesCurrent	310095	usd
CY2022Q3	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	539741	usd
CY2021Q4	strn	Right Of Use Asset Office Leases Non Current RightOfUseAssetOfficeLeasesNonCurrent	784683	usd
CY2022Q3	strn	Operating Leases OperatingLeases	864050	usd
CY2021Q4	strn	Operating Leases OperatingLeases	1094778	usd
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	333072	usd
CY2021Q3	us-gaap	Prepaid Rent PrepaidRent	292023	usd
CY2022Q3	strn	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	349412	usd
CY2022Q3	strn	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	323584	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10345784	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.9
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	271589	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.81
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10074195	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000000	usd
CY2022Q3	us-gaap	Shares Issued SharesIssued	1667545	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.9
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1667545	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6824085	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	212368	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-year contractual terms.
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1603000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1602997	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted	-68000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	66180	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.15
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj	-66177	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604820	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.09
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1604817	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	109924	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.11
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	109921	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1681409	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	264894	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19702136	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31381151	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10000000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	10074195	shares
CY2022Q3	strn	Shares Held In Employee Stock Warrants SharesHeldInEmployeeStockWarrants	1604820	shares
CY2022Q3	us-gaap	Shares Held In Employee Stock Option Plan Suspense Shares SharesHeldInEmployeeStockOptionPlanSuspenseShares	11679015	shares
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	48282	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	37281	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	318900	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-115038	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-270618	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	152319	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-9254	usd
	strn	Unrealized Loss On Short Term Investments UnrealizedLossOnShortTermInvestments		usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	76338	usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	113900	usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-44800	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-123154	usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	121138	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-393772	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	273457	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	174400	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	545800	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	0	usd
	us-gaap	Advertising Expense AdvertisingExpense	211945	usd
	us-gaap	Advertising Expense AdvertisingExpense	99241	usd
	strn	Major Revenues Percentage MajorRevenuesPercentage	0.104	pure
	strn	Accounts Receivable Percentage AccountsReceivablePercentage	0.138	pure
	dei	Local Phone Number LocalPhoneNumber	833-3309
	dei	City Area Code CityAreaCode	800
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2021Q3	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
	strn	Note Payable Line Of Credits NotePayableLineOfCredits		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	strn	Net Working Deficit Received In Asset Acquisition NetWorkingDeficitReceivedInAssetAcquisition		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	strn	Cost Of Intangible Asset Customer List CostOfIntangibleAssetCustomerList		usd
	strn	Equipment Acquired In Asset Acquisition EquipmentAcquiredInAssetAcquisition		usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
	strn	Non Cash Wildman Business Group Llc Asset Acquisition NonCashWildmanBusinessGroupLLCAssetAcquisition		usd
	strn	Non Cash Gap Promotions Llc Asset Acquisition NonCashGAPPromotionsLLCAssetAcquisition		usd
	strn	Non Cash Trend Inc Asset Acquisition NonCashTrendIncAssetAcquisition		usd
CY2022Q3	strn	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears		usd
CY2022Q3	strn	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years Beginning Balance WeightedAverageLifeYearsBeginningBalance
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years WeightedAverageLifeYears
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	strn	Weighted Average Life Years WeightedAverageLifeYears
	strn	Weighted Average Life Years Warrants Exercised WeightedAverageLifeYearsWarrantsExercised
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	strn	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj		usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021Q3	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated		shares
CY2021Q3	strn	Shares Held In Employee Stock Warrants SharesHeldInEmployeeStockWarrants		shares
CY2021Q3	us-gaap	Shares Held In Employee Stock Option Plan Suspense Shares SharesHeldInEmployeeStockOptionPlanSuspenseShares		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001872525

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
strn-20220930_cal.xml	Edgar Link	unprocessable
strn-20220930_def.xml	Edgar Link	unprocessable
strn-20220930_lab.xml	Edgar Link	unprocessable
strn-20220930_pre.xml	Edgar Link	unprocessable
0001213900-22-072154-index-headers.html	Edgar Link	pending
0001213900-22-072154-index.html	Edgar Link	pending
0001213900-22-072154.txt	Edgar Link	pending
0001213900-22-072154-xbrl.zip	Edgar Link	pending
f10q0922ex31-1_stranandco.htm	Edgar Link	pending
f10q0922ex31-2_stranandco.htm	Edgar Link	pending
f10q0922ex32-1_stranandco.htm	Edgar Link	pending
f10q0922ex32-2_stranandco.htm	Edgar Link	pending
f10q0922_stranandco.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
f10q0922_stranandco_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strn-20220930.xsd	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWAG
Stran & Company, Inc. Stock $swag

2022 Q4 Form 10-Q Financial Statement

#000121390022072154 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG Stran & Company, Inc. Stock $swag

2022 Q4 Form 10-Q Financial Statement

#000121390022072154 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG
Stran & Company, Inc. Stock $swag